Jim Bob Faulk, MD
Vascular Surgery · Nashville, TNNPI 1245237148
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,734 of the $12,685 with a category attached, or 84.6%. 30 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 36.4% of the total. Reporting peaked in 2022 at $2,927 and has fallen 75.8% since, to $707 in 2025.
Across 174 payments — averaging $72.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$5K
- Endologix LLC$2K
- Medtronic$2K
- Silk Road Medical, Inc.$1K
- Penumbra, Inc.$725
- Abbott$568
- plus $2K from 24 others
What the payments were for
- Travel & lodging$1,95015%
- Food & beverage$10,73485%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 51 | $4,616 |
| Endologix LLC | 6 | $2,050 |
| Medtronic(3 entities) | 19 | $1,611 |
| Silk Road Medical, Inc. | 10 | $1,121 |
| Penumbra, Inc. | 23 | $725 |
| Abbott | 5 | $568 |
| Aroa Biosurgery Incorporated | 6 | $454 |
| Inari Medical, Inc. | 8 | $428 |
| Cook Medical LLC | 6 | $192 |
| Sanara Medtech Inc. | 2 | $154 |
| Bolton Medical Inc | 4 | $98 |
| Lemaitre Vascular, Inc. | 4 | $98 |
| Innovation Technologies Inc | 3 | $90 |
| Surmodics, Inc. | 3 | $66 |
| Johnson & Johnson | 3 | $60 |
| Boston Scientific | 2 | $48 |
| Cagent Vascular Inc | 2 | $47 |
| Solventum Corporation | 2 | $40 |
| Bard Peripheral Vascular, Inc. | 2 | $33 |
| Smith+Nephew | 2 | $27 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 2 | $21 |
| Laminate Medical Technologies Inc. | 1 | $21 |
| Centerline Biomedical Inc. | 1 | $20 |
| TELA Bio, Inc. | 1 | $18 |
| Kerecis Limited | 1 | $16 |
| Endogastric Solutions, Inc | 1 | $16 |
| Shockwave Medical, Inc | 1 | $15 |
| Pfizer | 1 | $14 |
| Getinge USA Sales, LLC | 1 | $12 |
| Artivion, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ovation$1,697
- ENROUTE Transcarotid Neuroprotection System$1,261
- GORE TAG Thoracic Endoprosthesis$1,067
- ENROUTE Transcarotid Stent$887
- Endurant$635
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$607
- ENHANCE Transcarotid Peripheral Access Kit$550
- GORE EXCLUDER AAA Endoprosthesis$485
- GORE TAG Thoracic Branch Endoprosthesis$428
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$415
- ENROUTE .014 Guidewire$375
- AFX$353
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$324
- ESPRIT$314
- ENDURANT IIS$299
- Indigo System$296
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$199
- FLOWTRIEVER CATHETER, S$192
- CT THROMBECTOMY SYSTEM KIT$192
- ENROUTE Transcarotid Stent System$175
How this compares
$12,685 in reported general payments places this provider in the 70th percentile of 117 vascular surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 17 | $13,433 |
| Cilostazol | 122 | $2,016 |
| ClopidogrelClopidogrel Bisulfate | 130 | $1,204 |
| Atorvastatin Calcium | 36 | $528 |
| Methylprednisolone | 11 | $84 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $60 | $13,43317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 117 vascular surgery providers in Tennessee.
Other vascular surgery in Nashville
- Daniel ClairNashville$993K
- Patrick StoneNashville$46K
- Allen LeeNashville$39K
- Julia BollNashville$36K
- Thomas NaslundNashville$31K
- Lauren FryeNashville$20K
- Patrick RyanNashville$19K
- Mary NallyNashville$10K
- Sergio Sastriques DunlopNashville$10K
- Ziad Al AdasNashville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.